Frequency of NPM1 Mutation and Its Impact on Prognosis in Cytogenetically Normal AML Patients: Hyperleukocytosis Remains an Unfavorable Prognostic Marker Among NPM1 Positive Patients


Creative Commons License

Pepeler M. S., Özkurt Z. N., Kaya A., Gökçen S., Sunguroğlu A., Kayhan H., ...Daha Fazla

Acta haematologica oncologica Turcica, cilt.58, sa.3, ss.190-195, 2025 (TRDizin) identifier